Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Current Topics in Medicinal Chemistry|July 23, 2003
Development and potential utility of dual and triple NK receptor antagonistsCharles A Rizzo, John C Anthes, Michel R Corboz, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2002
Structure-activity relationships of oxime neurokinin antagonists: oxime modificationsGregory A Reichard, James Spitler, Robert Aslanian, et al.
Organic Letters|November 7, 2003
Asymmetric synthesis of 4,4-disubstituted-2-imidazoli-dinones: potent NK1 antagonistsGregory A Reichard, Carmine Stengone, Sunil Paliwal, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2005
The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: antagonists versus agonistsPauline C Ting, Shelby P Umland, Robert Aslanian, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2006
Cyclobutane derivatives as potent NK1 selective antagonistsMichelle Laci Wrobleski, Gregory A Reichard, Sunil Paliwal, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2002
Identification of a novel 1'-[5-((3,5-dichlorobenzoyl)methylamino)-3-(3,4-dichlorophenyl)-4-(methoxyimino)pentyl]-2-oxo-(1,4'-bipiperidine) as a dual NK(1)/NK(2) antagonistPauline C Ting, Joe F Lee, Neng Yang Shih, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2010
Discovery of a series of potent, orally active α,α-disubstituted piperidine NK(1) antagonistsDong Xiao, Cheng Wang, Anandan Palani, et al.
Bioorganic & Medicinal Chemistry|February 13, 2010
Discovery of potent sulfonamide P4-capped ketoamide second generation inhibitors of hepatitis C virus NS3 serine protease with favorable pharmacokinetic profiles in preclinical speciesStéphane L Bogen, Ashok Arasappan, Francisco Velazquez, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2002
Synthesis and structure-activity relationships of oxime neurokinin antagonists: discovery of potent arylamidesNeng Yang Shih, Margaret Albanese, John C Anthes, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2008
Discovery of a novel, potent and orally active series of gamma-lactams as selective NK1 antagonistsSunil Paliwal, Gregory A Reichard, Sapna Shah, et al.
Pageof 7